Connect your AI

OS Therapies OSTX Convertible Preferred Stock Outstanding Shares

Convertible Preferred Stock Outstanding Shares at other companies

CelcuityCELC

0-100%

Lesaka Technologies, Inc.LSAK

0—

Rigel PharmaceuticalsRIGL

0—

Hour Loop, Inc.HOUR

0—

NextNRG, Inc. Common StockNXXT

0—

Edgewell Personal CareEPC

0—

Other financials

Income statement

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

Market cap$84.62M+65.5%

Enterprise value$103.7M—

Returns & leverage

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's convertible preferred stock outstanding shares.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is OS Therapies's convertible preferred stock outstanding shares?: OS Therapies (OSTX) reported convertible preferred stock outstanding shares of 0 in Q1 2026.
What does convertible preferred stock outstanding shares mean?: This indicates the total volume of preferred equity shares that carry conversion rights into common stock. It provides insight into the company's capital structure and the potential impact on common shareholder ownership upon conversion.